Merck Protillion Collaboration Sends MRK Soaring 15%

Can the Merck Protillion Collaboration really help MRK outrun its post-Keytruda patent fears and justify Wall Street’s sudden excitement? Maik Kemper Editor in Chief This isn’t incremental —…